Log in to save to my catalogue

Implications of mRNA-based SARS-CoV-2 vaccination for cancer patients

Implications of mRNA-based SARS-CoV-2 vaccination for cancer patients

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8b6d974d24a64609a432866255690ad6

Implications of mRNA-based SARS-CoV-2 vaccination for cancer patients

About this item

Full title

Implications of mRNA-based SARS-CoV-2 vaccination for cancer patients

Publisher

England: BMJ Publishing Group Ltd

Journal title

Journal for immunotherapy of cancer, 2021-06, Vol.9 (6), p.e002932

Language

English

Formats

Publication information

Publisher

England: BMJ Publishing Group Ltd

More information

Scope and Contents

Contents

SARS-CoV-2 infection and the resulting COVID-19 have afflicted millions of people in an ongoing worldwide pandemic. Safe and effective vaccination is needed urgently to protect not only the general population but also vulnerable subjects such as patients with cancer. Currently approved mRNA-based SARS-CoV-2 vaccines seem suitable for patients with...

Alternative Titles

Full title

Implications of mRNA-based SARS-CoV-2 vaccination for cancer patients

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_8b6d974d24a64609a432866255690ad6

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8b6d974d24a64609a432866255690ad6

Other Identifiers

ISSN

2051-1426

E-ISSN

2051-1426

DOI

10.1136/jitc-2021-002932

How to access this item